V

Varian

Tech-enabled radiation oncology hardware and software

Head of Site Manufacturing - Point of Care

Full-Time
$240k - $330k+ Commission
Expert
Bachelor's
United States
In Person
Manufacturing & Production Operations
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in engineering, manufacturing, operations, supply chain, business administration, or a comparable discipline is required.
  • Extensive, progressive leadership experience in manufacturing or operations is required, ideally within medical technology, diagnostics, life sciences, pharmaceuticals, or another highly regulated industry.
  • Experience leading a complex manufacturing site or substantial multi-layer production organization with accountability for operational and financial results is required.
  • Strong knowledge of regulated manufacturing, quality-management systems, EHS requirements, and risk-based operational decision-making is required.
  • A successful track record in operational excellence, lean transformation, productivity improvement, and sustainable change management is required.
  • Understanding of production planning, capacity management, materials flow, inventory, industrial engineering, and manufacturing technology is required.
  • Experience leading product industrialization, technology transfer, ramp-up, or major site transformation initiatives is required.
  • Comfort using data, digital tools, and performance analytics to drive decisions, transparency, and continuous improvement is required.
  • Fluency in English is required; local language requirements depend on the site.
  • A visible, credible, people-centered leadership approach that sets clear expectations and creates ownership at every level is required.
  • Strategic perspective combined with hands-on operational discipline and decisiveness in complex or time-critical situations is required.
  • Patient and customer impact must be central to operational decisions, without compromising safety, quality, or integrity.
  • Ability to navigate a global matrix, build trust across functions, and influence stakeholders without relying solely on hierarchy is required.
  • Ability to communicate complex topics clearly, address performance issues constructively, and create an environment where risks are raised early is required.
  • Ability to challenge the status quo thoughtfully, simplify complexity, and convert improvement opportunities into sustained business outcomes is required.
  • Ability to develop diverse talent, strengthen succession, and encourage learning, inclusion, and healthy dialogue is required.
Responsibilities
  • Lead end-to-end manufacturing performance at the site, including safety, quality, delivery, cost, productivity, and people outcomes.
  • Translate Point of Care business and manufacturing strategy into a site roadmap, operating plan, targets, and measurable performance indicators.
  • Align capacity, materials, equipment, workforce, and contingency plans with demand to ensure reliable production output and customer supply.
  • Establish performance management routines, identify root causes, and ensure timely, sustainable corrective and preventive actions.
  • Ensure manufacturing activities meet applicable regulatory requirements, quality-system requirements, and company standards, and build a strong quality and compliance culture.
  • Lead continuous improvement through the Healthineers Performance System and lean methods, including value-stream optimization, structured problem solving, visual management, and coaching.
  • Drive productivity, cost competitiveness, technology, and automation initiatives while safeguarding product quality, employee safety, and supply continuity.
  • Oversee site operating budgets, investments, and financial performance, with disciplined prioritization and transparent business cases.
  • Partner with Quality, Supply Chain, Procurement, Engineering, R&D, Finance, EHS, HR, IT, and other sites to resolve issues, industrialize products, and optimize the manufacturing network.
  • Ensure manufacturing readiness for new products, transfers, and lifecycle changes through effective risk management and cross-functional governance.
  • Develop the site organization, leadership team, and succession pipeline, and create an inclusive, accountable, learning-oriented culture.
  • Represent the site in business and functional governance and maintain constructive relationships with relevant internal and external stakeholders.
Desired Qualifications
  • An advanced degree is an advantage.
  • Manufacturing or operations leadership experience in medical technology, diagnostics, life sciences, pharmaceuticals, or another highly regulated industry is ideal.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.